Anti D 300mcg Injection PFS contains active components called Anti-Rh(D) immunoglobulin . It is a medication used to prevent Rh(D) hemolytic disease of the newborn (HDN). This condition can occur when an Rh-negative mother carries an Rh-positive baby. It significantly reduces the risk of Rh-negative mothers developing antibodies against Rh(D) antigens, which could otherwise lead to HDN in subsequent pregnancies.

Individuals with a known severe allergy or hypersensitivity to any component of Anti D 300mcg Injection PFS should not receive the medication. It should not be given to Rh-positive mothers as they already have Rh(D) antigens on their red blood cells and cannot develop Rh antibodies. If a woman is already sensitized to Rh(D) antigens (meaning she has developed Rh antibodies in a previous pregnancy or event), administering this medication will not reverse the sensitization. It is only effective as a preventive measure and should not be given in this situation.

Anti D 300mcg Injection PFS is generally considered safe for use in elderly individuals, provided they meet the necessary criteria for administration based on their blood type and medical history. It can be administered to children when it is medically necessary to prevent Rh sensitization.

Prevention of Rh Sensitization

Prevention of Rh Hemolytic Disease of the Newborn (HDN)

Preventing Alloimmunization

Anti D 300mcg Injection PFS involves the binding of Rh-Ig antibodies to Rh-positive fetal blood cells that enter the maternal bloodstream during pregnancy or childbirth. By covering the Rh(D) antigens on these fetal blood cells, Rh-Ig prevents the mother's immune system from recognizing them as foreign and producing antibodies against them. This neutralization of Rh-positive fetal blood cells effectively prevents Rh sensitization, ensuring the mother's immune system does not develop antibodies that could lead to hemolytic disease of the newborn (HDN) in subsequent pregnancies.

Anti D 300mcg Injection PFS (Rh-Ig) can be administered through two primary routes: intramuscular (IM) injection and intravenous (IV) injection. The doctor chooses the administration route based on the patient's needs and preferences.

Allergic reactions

Blood Clots (thromboembolism)

Kidney issues

Infections

Local reactions

Low-grade fever

Inform the doctor about your medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Anti D 300mcg Injection PFS, reducing effectiveness by causing undesirable side effects.

Stored at room temperature from 2-8°C.

Keep away from moisture, heat, and light.

It should not be frozen.

Keep away from children and pets.

When using Anti D 300mcg Injection PFS, healthcare providers should exercise precautions such as confirming the patient's Rh blood type, monitoring for allergic reactions (especially in those with known allergies), assessing clotting risk, closely observing patients with kidney issues, educating about infection transmission risks, considering vaccination timing, evaluating safety during pregnancy and breastfeeding, screening for hepatitis B, administering accurate dosages, being aware of potential drug interactions, ensuring proper storage, monitoring for Rh sensitization efficacy, adjusting dosages for pediatric and geriatric patients, and assessing patients with compromised immune systems or underlying conditions. These precautions help ensure the safe and effective use of this medication for each patient's specific clinical needs while minimizing potential risks.